Primary Hyperoxaluria Type III Gene HOGA1 (Formerly DHDPSL) as a Possible Risk Factor for Idiopathic Calcium Oxalate Urolithiasis
Open Access
- 1 September 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 6 (9), 2289-2295
- https://doi.org/10.2215/cjn.02760311
Abstract
Background and objectives Primary hyperoxaluria types I and II (PHI and PHII) are rare monogenic causes of hyperoxaluria and calcium oxalate urolithiasis. Recently, we described type III, due to mutations in HOGA1 (formerly DHDPSL), hypothesized to cause a gain of mitochondrial 4-hydroxy-2-oxoglutarate aldolase activity, resulting in excess oxalate. Design, setting, participants, & measurements To further explore the pathophysiology of HOGA1, we screened additional non-PHI-PHII patients and performed reverse transcription PCR analysis. Postulating that HOGA1 may influence urine oxalate, we also screened 100 idiopathic calcium oxalate stone formers. Results Of 28 unrelated hyperoxaluric patients with marked hyperoxaluria not due to PHI, PHII, or any identifiable secondary cause, we identified 10 (36%) with two HOGA1 mutations (four novel, including a nonsense variant). Reverse transcription PCR of the stop codon and two common mutations showed stable expression. From the new and our previously described PHIII cohort, 25 patients were identified for study. Urine oxalate was lower and urine calcium and uric acid were higher when compared with PHI and PHII. After 7.2 years median follow-up, mean eGFR was 116 ml/min per 1.73 m2. HOGA1 heterozygosity was found in two patients with mild hyperoxaluria and in three of 100 idiopathic calcium oxalate stone formers. No HOGA1 variants were detected in 166 controls. Conclusions These findings, in the context of autosomal recessive inheritance for PHIII, support a loss-of-function mechanism for HOGA1, with potential for a dominant-negative effect. Detection of HOGA1 variants in idiopathic calcium oxalate urolithiasis also suggests HOGA1 may be a predisposing factor for this condition.Keywords
This publication has 15 references indexed in Scilit:
- Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type IIIAmerican Journal of Human Genetics, 2010
- Phenotypic and Functional Analysis of Human SLC26A6 Variants in Patients With Familial Hyperoxaluria and Calcium Oxalate NephrolithiasisAmerican Journal of Kidney Diseases, 2008
- Hydroxyproline ingestion and urinary oxalate and glycolate excretionKidney International, 2006
- Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or IIKidney International, 2002
- Hyperoxaluria and Urolithiasis in Young Children: An Atypical PresentationJournal of Endourology, 1999
- GLYOXYLATE SYNTHESIS, AND ITS MODULATION AND INFLUENCE ON OXALATE SYNTHESISJournal of Urology, 1998
- Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: A novel type of primary hyperoxaluriaKidney International, 1996
- Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type IFEBS Letters, 1986
- Hydroxyproline metabolism by the rat kidney: Distribution of renal enzymes of hydroxyproline catabolism and renal conversion of hydroxyproline to glycine and serineMetabolism, 1985
- The Cause of Idiopathic Calcium Stone Disease: Hypercalciuria or Hyperoxaluria?Nephron, 1980